Published data from Moderna COVID-19 vaccine trial show 94.1 percent efficacy

BOSTON — A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc. Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine can prevent symptomatic infection. […]

Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone

Bottom Line: Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival. Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research Author: David A. Reardon, MD, clinical director of the […]

Moderna’s COVID-19 vaccine shows 95% efficacy

US company second to report impressive efficacy for its COVID-19 vaccine candidate. Color-enhanced transmission electron micrograph of SARS-CoV-2 virus particles. Image credit: NIAID In an announcement made today, the US-based biotech company Moderna has reported that its vaccine candidate against COVID-19, mRNA-1273, has met the statistical criteria for efficacy, with a vaccine efficacy of 94.5%. […]

Burt’s Bees presents clinical data on brand’s natural lip and anti-aging skincare efficacy

DURHAM, N.C., October 23, 2020 – Burt’s Bees, a pioneer in natural skin care, today announced new research supporting the role of efficacy-first, natural regimens to defend, replenish and restore vibrant, healthier-looking skin. The studies will be presented at the virtual Integrative Dermatology Symposium (IDS) from October 23 – November 1, 2020. The latest research […]